Fusen Pharmaceutical Company Limited
HKEX:1652.HK
1 (HKD) • At close September 11, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||
Current Assets: | |||||||||
Cash & Cash Equivalents
| 34.849 | 128.106 | 81.063 | 297.038 | 331.044 | 561.108 | 474.621 | 244.39 | 32.569 |
Short Term Investments
| 0 | 4.595 | 0.642 | 15.489 | -19.821 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 34.849 | 128.106 | 81.705 | 312.527 | 331.044 | 561.108 | 474.621 | 244.39 | 32.569 |
Net Receivables
| 183.482 | 247.189 | 157.581 | 183.93 | 170.164 | 120.344 | 109.115 | 123.027 | 208.8 |
Inventory
| 161.718 | 110.649 | 121.845 | 105.415 | 88.404 | 140.787 | 100.506 | 100.779 | 106.633 |
Other Current Assets
| 186.753 | 110.678 | 140.963 | 71.896 | 80.138 | 181.87 | 177.622 | 599.741 | 1,016.963 |
Total Current Assets
| 566.802 | 614.056 | 509.222 | 660.367 | 674.395 | 883.765 | 752.749 | 944.91 | 1,156.165 |
Non-Current Assets: | |||||||||
Property, Plant & Equipment, Net
| 352.007 | 314.37 | 285.46 | 238.002 | 124.676 | 154.445 | 192.014 | 199.583 | 198.12 |
Goodwill
| 0 | 0 | 0 | 0 | 7.054 | 0 | 0 | 0 | 0 |
Intangible Assets
| 255.553 | 215.858 | 221.257 | 248.809 | 270.646 | 117.908 | 1.483 | 1.683 | 1.883 |
Goodwill and Intangible Assets
| 255.553 | 215.858 | 221.257 | 248.809 | 277.7 | 117.908 | 1.483 | 1.683 | 1.883 |
Long Term Investments
| 148.974 | 173.714 | 197.422 | 52.159 | 91.924 | 0 | -4.974 | -4.912 | -5.309 |
Tax Assets
| 5.021 | 5.079 | 5.629 | 5.709 | 5.408 | 4.84 | 4.974 | 4.912 | 5.309 |
Other Non-Current Assets
| 15.388 | 27.191 | 20.346 | 36.301 | 2.126 | 2.304 | 4.974 | 4.912 | 5.309 |
Total Non-Current Assets
| 776.943 | 736.212 | 730.114 | 580.98 | 501.834 | 279.497 | 198.471 | 206.178 | 205.312 |
Total Assets
| 1,343.745 | 1,350.268 | 1,239.336 | 1,241.347 | 1,176.229 | 1,163.262 | 951.22 | 1,151.088 | 1,361.477 |
Liabilities & Equity: | |||||||||
Current Liabilities: | |||||||||
Account Payables
| 167.545 | 163.613 | 102.115 | 108.585 | 68.898 | 137.991 | 130.224 | 137.653 | 183.529 |
Short Term Debt
| 237.643 | 227.949 | 162.748 | 178.5 | 190 | 100 | 360 | 571.492 | 636.662 |
Tax Payables
| 22.342 | 31.828 | 28.834 | 35.562 | 40.776 | 62.222 | 63.693 | 48.717 | 26.476 |
Deferred Revenue
| -1.087 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 260.419 | 330.52 | 224.403 | 260.521 | 201.908 | 213.008 | 241.754 | 285.483 | 196.616 |
Total Current Liabilities
| 664.52 | 722.082 | 489.266 | 547.606 | 460.806 | 450.999 | 731.978 | 994.628 | 1,016.807 |
Non-Current Liabilities: | |||||||||
Long Term Debt
| 106.472 | 0.432 | 77.94 | 20 | 20 | 90 | 31.6 | 29.186 | 149.6 |
Deferred Revenue Non-Current
| 10.231 | 11.323 | 10.508 | 8.359 | 6.752 | 4.472 | 4.865 | 0.665 | 0.875 |
Deferred Tax Liabilities Non-Current
| 0.296 | 3.538 | 4.678 | 7.133 | 7.131 | 1.692 | -4.865 | -0.665 | -0.875 |
Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 4.865 | 0.665 | 0.875 |
Total Non-Current Liabilities
| 116.999 | 15.293 | 93.126 | 35.492 | 33.883 | 96.164 | 36.465 | 29.851 | 150.475 |
Total Liabilities
| 781.519 | 737.375 | 582.392 | 583.098 | 494.689 | 547.163 | 768.443 | 1,024.479 | 1,167.282 |
Equity: | |||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 6.31 | 6.383 | 6.479 | 6.513 | 6.732 | 6.732 | 1.274 | 71.633 | 71.445 |
Retained Earnings
| 238.536 | 274.813 | 309.418 | 346.844 | 276.713 | 223.279 | 122.647 | 44.049 | 112.661 |
Accumulated Other Comprehensive Income/Loss
| 557.208 | 32.219 | 28.786 | 31.331 | 14.057 | -116.061 | -108.971 | -92.589 | -87.661 |
Other Total Stockholders Equity
| -238.536 | 300.752 | 313.486 | 274.754 | 375.943 | 499.985 | 165.615 | 97.972 | 93.138 |
Total Shareholders Equity
| 563.518 | 614.167 | 658.169 | 659.442 | 673.445 | 613.935 | 180.565 | 121.065 | 189.583 |
Total Equity
| 562.226 | 612.893 | 656.944 | 658.249 | 681.54 | 616.099 | 182.777 | 126.609 | 194.195 |
Total Liabilities & Shareholders Equity
| 1,343.745 | 1,350.268 | 1,239.336 | 1,241.347 | 1,176.229 | 1,163.262 | 951.22 | 1,151.088 | 1,361.477 |